List of Tables
Table 1. Long-Acting Injectable (LAI) Antipsychotic Market Trends
Table 2. Long-Acting Injectable (LAI) Antipsychotic Market Drivers & Opportunity
Table 3. Long-Acting Injectable (LAI) Antipsychotic Market Challenges
Table 4. Long-Acting Injectable (LAI) Antipsychotic Market Restraints
Table 5. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Long-Acting Injectable (LAI) Antipsychotic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Long-Acting Injectable (LAI) Antipsychotic Product Type
Table 9. Key Companies Time to Begin Mass Production of Long-Acting Injectable (LAI) Antipsychotic
Table 10. Global Long-Acting Injectable (LAI) Antipsychotic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectable (LAI) Antipsychotic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Long-Acting Injectable (LAI) Antipsychotic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Long-Acting Injectable (LAI) Antipsychotic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Long-Acting Injectable (LAI) Antipsychotic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Long-Acting Injectable (LAI) Antipsychotic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Region (2019-2024) & (%)
Table 27. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Long-Acting Injectable (LAI) Antipsychotic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2025-2030) & (US$ Million)
Table 31. Alkermes Basic Information List
Table 32. Alkermes Description and Business Overview
Table 33. Alkermes Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Alkermes (2019-2024)
Table 35. Alkermes Recent Developments
Table 36. Eli Lilly and Company Basic Information List
Table 37. Eli Lilly and Company Description and Business Overview
Table 38. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Eli Lilly and Company (2019-2024)
Table 40. Eli Lilly and Company Recent Developments
Table 41. Janssen Global Services, LLC Basic Information List
Table 42. Janssen Global Services, LLC Description and Business Overview
Table 43. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Janssen Global Services, LLC (2019-2024)
Table 45. Janssen Global Services, LLC Recent Developments
Table 46. Abilify Maintena Basic Information List
Table 47. Abilify Maintena Description and Business Overview
Table 48. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Abilify Maintena (2019-2024)
Table 50. Abilify Maintena Recent Developments
Table 51. Haldol Basic Information List
Table 52. Haldol Description and Business Overview
Table 53. Haldol Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Haldol (2019-2024)
Table 55. Haldol Recent Developments
Table 56. Otsuka Pharmaceutical Basic Information List
Table 57. Otsuka Pharmaceutical Description and Business Overview
Table 58. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Otsuka Pharmaceutical (2019-2024)
Table 60. Otsuka Pharmaceutical Recent Developments
Table 61. Aristada Basic Information List
Table 62. Aristada Description and Business Overview
Table 63. Aristada Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Aristada (2019-2024)
Table 65. Aristada Recent Developments
Table 66. Prolixin Basic Information List
Table 67. Prolixin Description and Business Overview
Table 68. Prolixin Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Prolixin (2019-2024)
Table 70. Prolixin Recent Developments
Table 71. Sumitomo Dainippon Pharma Basic Information List
Table 72. Sumitomo Dainippon Pharma Description and Business Overview
Table 73. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Long-Acting Injectable (LAI) Antipsychotic Business of Sumitomo Dainippon Pharma (2019-2024)
Table 75. Sumitomo Dainippon Pharma Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Long-Acting Injectable (LAI) Antipsychotic Downstream Customers
Table 79. Long-Acting Injectable (LAI) Antipsychotic Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Long-Acting Injectable (LAI) Antipsychotic Product Picture
Figure 2. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value (2019-2030) & (US$ Million)
Figure 4. Long-Acting Injectable (LAI) Antipsychotic Report Years Considered
Figure 5. Global Long-Acting Injectable (LAI) Antipsychotic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-Acting Injectable (LAI) Antipsychotic Revenue in 2023
Figure 7. Long-Acting Injectable (LAI) Antipsychotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Aripiprazole Picture
Figure 9. Fluphenazine Picture
Figure 10. Haloperidol Picture
Figure 11. Others Picture
Figure 12. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital
Figure 15. Product Picture of Retail Pharmacy
Figure 16. Product Picture of Others
Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Long-Acting Injectable (LAI) Antipsychotic Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Long-Acting Injectable (LAI) Antipsychotic Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Long-Acting Injectable (LAI) Antipsychotic Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Long-Acting Injectable (LAI) Antipsychotic Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Long-Acting Injectable (LAI) Antipsychotic Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Long-Acting Injectable (LAI) Antipsychotic Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Long-Acting Injectable (LAI) Antipsychotic Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Long-Acting Injectable (LAI) Antipsychotic Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Long-Acting Injectable (LAI) Antipsychotic Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Long-Acting Injectable (LAI) Antipsychotic Sales Value (%), (2019-2030)
Figure 30. United States Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (%), 2023 VS 2030
Figure 36. China Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (%), 2023 VS 2030
Figure 38. China Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (%), 2023 VS 2030
Figure 48. India Long-Acting Injectable (LAI) Antipsychotic Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Long-Acting Injectable (LAI) Antipsychotic Sales Value by Type (%), 2023 VS 2030
Figure 50. India Long-Acting Injectable (LAI) Antipsychotic Sales Value by Application (%), 2023 VS 2030
Figure 51. Long-Acting Injectable (LAI) Antipsychotic Industrial Chain
Figure 52. Long-Acting Injectable (LAI) Antipsychotic Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation